Inconsistent with in silico results, the expression of SFRP1 (5.7-fold down, p-value < 0.001) and SFRP2 genes (15.3-fold down, p-value < 0.001) in CRC samples exhibited a substantial decrease compared to the adjacent normal tissues. The gene discussed is SFRP2; the disease is colorectal carcinoma.